Pro Medicus (ASX:PME) signed a convertible note debt and option agreement with Echo IQ (ASX:EIQ), representing the execution of an agreement the companies struck in June, according to a Monday filing with the Australian bourse.
Under the agreement, Pro Medicus will invest up to AU$20 million in Echo IQ and become a reseller of the EchoSolv product suite across the US, an earlier filing showed.
Pro Medicus' shares fell nearly 2% in recent Monday trade, while Echo IQ's shares gained nearly 3%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments